A new study published today in Cancer Discovery, a journal of the American Association for Cancer Research, reports findings that may change the understanding of how synovial sarcoma develops and...
Huntsman Cancer Institute has announced this year’s recipients of the Susan Cooper Jones Endowed Fellowship in Cancer Research – Helen Lillie, Helong Zhao and Peng Zhang.
Six new cancer researchers will receive funding through the 5 For The Fight Cancer Research Fellowship, which aims to bring innovative ideas and new ways of thinking to eradicate cancer.
Huntsman Cancer Institute highlights two examples of clinical trials at HCI exploring new innovations in cancer, including the I-SPY2 trial, studying new approaches for breast cancer treatment, and the SWOG...
A study published today in the Journal of Clinical Oncology expands on evidence of lower health care costs and fewer unplanned health care visits in an acute care model of...
Researchers at Huntsman Cancer Institute have found critical new insights into how cells defend against melanoma. In a report published in Nature Communications, the team describes how an enzyme called...
Siqi Hu, PhD, is a member of the Hashibe Lab at Huntsman Cancer Institute. Hu presented results at the 2021 virtual American Association for Cancer Research Annual Meeting that women...
Utah had more melanoma deaths than any other state from 1975 to 2013, says a letter published today by HCI researchers in the New England Journal of Medicine. In contrast...
Clinical trials bring hope to patients in the form of innovative treatments. During the COVID-19 pandemic, despite strict hospital safety protocols and staff switching to remote work, HCI clinical research...
Every five to seven years, HCI goes through a rigorous application process to maintain status as a National Cancer Institute-Designated Comprehensive Cancer Center and prove we meet the highest national...
Huntsman Cancer Institute is dedicated to creating an environment that not only promotes—but insists upon—equity, diversity, and inclusion. Read highlights of noteworthy programs and research from the Cancer Control and...
In March 2020, COVID-19 led to restrictions in on-site activities at HCI, at the ÑÇÖÞ×ÔοÊÓƵ of Utah, across the state, and throughout the nation. HCI researchers were determined to keep...
When cancer researchers from different disciplines work together, they gain new insights into how cancer begins and how it can be treated. HCI is committed to providing an atmosphere where...
The Accelerator at the ÑÇÖÞ×ÔοÊÓƵ of Utah, headed by Dr. David Bearss, is working in conjunction with the Huntsman Cancer Institute, the College of Pharmacy, and the Partners for Innovation...
An international group of cancer clinical research experts reported new recommendations that receiving a COVID-19 vaccination should not preclude a cancer patient from participating on a clinical trial. Huntsman Cancer...
